National legislation designed to standardize medication and safety protocols in horse racing passed the House of Representatives with bipartisan support Tuesday. A form of the Horseracing Integrity and Safety Act has been around since 2015, but it never had the traction to make it onto the House floor until this year.
Sen. Mitch McConnell, R-Ky., has introduced the same bill in the Senate, although there is no date set for committee markup or a vote. It is expected to pass before the end of the year.
The House bill was introduced by Paul Tonko, D-N.Y., who represents the area around Saratoga, and Andy Barr, R-Ky., who represents the area around Keeneland and horse farms near Lexington.
The bill has support from all the major racetrack organizations and animal welfare groups. It is, though, a concept with some broad principles rather than a specific plan to be executed at the state level. Currently, there are 38 different jurisdictions that regulate horse racing.
“(Tuesday’s) historic passage … by an overwhelmingly favorable bipartisan vote reflects broad industry support of much-needed national standards for anti-doping and medication control as well as racetrack safety,” said Alex Waldrop, president and chief executive of the National Thoroughbred Racing Association.
While the idea is to standardize rules and regulations across the country, there appears to be some room for states to impose their own rules, which would no longer make it a national standard. If horse racing is truly standardized, some jurisdictions may have to relax their regulations.
New Jersey, for example, recently outlawed the use of the riding crop, also called a whip, except in the case of safety. It’s the most strict rule in the country. A new whip rule goes into effect in California on Thursday in which a horse can be struck no more than six times and only in an underhand motion.
The Horsemen’s Benevolent and Protective Association, which represents around 30,000 owners and trainers, has been the most vocal in its opposition to the bill. Among its objections is the proposed banning of the drug Lasix, which is used to treat exercise-induced bleeding from the lungs. The HBPA contends there have not been enough veterinary studies conducted to justify this move.
Sen. Dianne Feinstein, D-Calif., is one of the co-sponsors of the Senate bill, but the California Horse Racing Board has reservations about the bill’s passage. At Thursday’s CHRB meeting, Executive Director Scott Chaney expressed concern over fears that standards could be relaxed or that the highly respected University of California, Davis laboratory might be shut out of testing if it is taken over by the U.S. Anti-Doping Agency as the bill proposes. The board, though has not taken a formal position on the matter.
———
©2020 Los Angeles Times
Visit the Los Angeles Times at www.latimes.com
Distributed by Tribune Content Agency, LLC.